BancorpSouth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$233K Sell
2,727
-556
-17% -$45.6K 0.02% 226
2017
Q2
$270K Sell
3,283
-158
-5% -$12.9K 0.03% 187
2017
Q1
$290K Hold
3,441
0.03% 176
2016
Q4
$253K Buy
+3,441
New +$256K 0.03% 184
2014
Q4
Sell
-3,744
Closed -$243K 266
2014
Q3
$243K Sell
3,744
-105
-3% -$6.65K 0.03% 227
2014
Q2
$239K Sell
3,849
-1,181
-23% -$70.5K 0.02% 232
2014
Q1
$296K Sell
5,030
-587
-10% -$32.8K 0.03% 193
2013
Q4
$286K Sell
5,617
-59
-1% -$2.96K 0.03% 188
2013
Q3
$286K Sell
5,676
-893
-14% -$46.8K 0.03% 178
2013
Q2
$322K Buy
+6,569
New +$357K 0.04% 165

Other funds holding LLY

BancorpSouth's LLY Position: Q3 2017 in Review

BancorpSouth reduced its Eli Lilly (LLY) stake by 17% in Q3 2017, selling an estimated $45.6K and leaving 2,727 shares worth $233K. The position accounts for 0.02% of the portfolio, ranked #226.

BancorpSouth first reported a position in LLY in Q2 2013 and has held it in 10 quarters since. The position peaked at $322K in Q2 2013. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

  • BancorpSouth held 2,727 shares of Eli Lilly worth $233K as of Q3 2017.
  • BancorpSouth sold 556 Eli Lilly shares in Q3 2017, an estimated $45.6K.
  • Eli Lilly made up 0.02% of BancorpSouth's portfolio in Q3 2017, its #226 holding.
  • BancorpSouth first reported a position in Eli Lilly in Q2 2013 and has held it in 10 quarters since.
  • BancorpSouth's Eli Lilly position peaked at $322K in Q2 2013.
  • 1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.